Abstract:Pre-eclampsia is a pregnancy-specific disease commonly occurring in late pregnancy and has always been threatening maternal and fetal lives, yet the etiology and pathogenesis of pre-eclampsia are still uncertain. To depict the overall changes of genes at the genome-wide level and identify potential biomarkers for early diagnosis of pre-eclampsia, we conducted this study by collecting placenta samples donated by six pregnancy women, among whom three healthy women were included as controls and three women were diagnosed with pre-eclampsia. The placental sample tissues were then subjected to high-throughput sequencing. Furthermore, we proceeded with bioinformatics analysis and formulated the hypothesis of pre-eclampsia development and verified the potential targets of pre-eclampsia by immunohistochemistry. Demographically, we found that the baseline characteristics of study subjects were highly homogeneous except for gestational weeks and blood pressure, where the blood pressure was higher and gestational weeks were shorter in the pre-eclampsia group (systolic blood pressure 123.33 ± 4.62 vs. 148.67 ± 3.79 mmHg, p = 0.046; diastolic blood pressure 79.00 ± 5.20 vs. 88.33 ± 2.89 mmHg, p = 0.068; gestational weeks 39.33 ± 1.03 vs. 35.76 ± 2.41, p = 0.050). Specific pathological changes were identified, shown as syncytial knots, fibrinoid necrosis, perivillous fibrin deposition, and vasculitis. For high-throughput sequencing, a total of 1,891 dysregulated genes were determined, of which 960 genes were downregulated and 931 genes were upregulated. The bioinformatics analysis indicated that these genes, with different molecular functions in different parts of cells, were primarily responsible for endothelium development and vascular process in the circulatory system, and more than 10 signaling pathways were involved. By focusing on the PI3K-Akt signaling pathway, Rap1 signaling pathway, and disease enrichment analysis item pre-eclampsia, TEK, CSF1, IGF1, and ANGPT2 were identified to promote the development of pre-eclampsia. After confirming the placental expression of these genes at the protein level, we proposed the pathogenesis of pre-eclampsia as follows: the downregulation of TEK, CSF1, IGF1, and ANGPT2 may inhibit trophoblast proliferation and affect the remodeling of spiral arteries, causing maternal and fetal malperfusion and impeding nutrient exchange, thereby leading to clinical manifestations of pre-eclampsia.

Is Human Placenta Proteoglycan Remodeling Involved in Pre-Eclampsia?

Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.

Integrated Proteomic and N-Glycoproteomic Profiling of Placental Tissues of Patients with Preeclampsia.

Proteomics Analysis of Human Placenta Reveals Glutathione Metabolism Dysfunction As the Underlying Pathogenesis for Preeclampsia

Comparative N-Glycoproteomic And Phosphoproteomic Profiling Of Human Placental Plasma Membrane Between Normal And Preeclampsia Pregnancies With High-Resolution Mass Spectrometry

[Expression and Clinical Significance of Platelet-Derived Growth Factor A in Placenta of Pre-Eclampsia.].

Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia

Human placenta-based genome-wide mRNA sequencing to identify TEK/IGF1/CSF1/ANGPT2 as crucial segments in the pathogenesis of pre-eclampsia

Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies

Placental Trophoblast Cell Differentiation: Physiological Regulation and Pathological Relevance to Preeclampsia

Placental Methylglyoxal in Preeclampsia: Vascular and Biomarker Implications

Screening and Functional Analysis of the Differential Peptides from the Placenta of Patients with Healthy Pregnancy and Preeclampsia Using Placental Peptidome

Placental glycosylation senses the anti-angiogenic milieu induced by human sFLT1 during pregnancy

Quantitative chemoproteomics reveals O-GlcNAcylation of cystathionine γ-lyase (CSE) represses trophoblast syncytialization

Comparative Proteomics Analysis Suggests That Placental Mitochondria Are Involved In The Development Of Pre-Eclampsia

Disaccharide compositional analysis of chondroitin sulphate using WAX HILIC-MS with pre-column procainamide labelling; application to the placenta in pre-eclampsia

Expression of G-protein subunit α-14 is increased in human placentas from preeclamptic pregnancies.

Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia

Gadd45 Alpha As An Upstream Signaling Molecule Of P38 Mapk Triggers Oxidative Stress-Induced Sflt-1 And Seng Upregulation In Preeclampsia

A comprehensive analysis of metabolomics and transcriptomics to reveal major metabolic pathways and potential biomarkers of human preeclampsia placenta

Abstract 580: Apoptotic Signaling Is Augmented In Preeclampsia: An Adverse Impact On The Offspring